Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
218.1 USD | +18.89% | +21.92% | +26.76% |
Sales 2024 * | 4.67B 6.38B | Sales 2025 * | 5.02B 6.87B | Capitalization | 32.03B 43.79B |
---|---|---|---|---|---|
Net income 2024 * | 1.02B 1.4B | Net income 2025 * | 1.22B 1.66B | EV / Sales 2024 * | 6.97 x |
Net Debt 2024 * | 522M 714M | Net cash position 2025 * | 354M 484M | EV / Sales 2025 * | 6.31 x |
P/E ratio 2024 * |
31.4
x | P/E ratio 2025 * |
26.9
x | Employees | 10,140 |
Yield 2024 * |
0.9% | Yield 2025 * |
0.98% | Free-Float | 77.06% |
Latest transcript on ResMed, Inc.
1 day | +18.89% | ||
1 week | +21.92% | ||
Current month | +10.11% | ||
1 month | +11.07% | ||
3 months | +14.68% | ||
6 months | +61.95% | ||
Current year | +26.76% |
Managers | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Brett Sandercock
DFI | Director of Finance/CFO | 57 | 97-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 51 | 00-08-31 |
Ron Taylor
BRD | Director/Board Member | 76 | 04-12-31 |
Peter Farrell
FOU | Founder | 81 | 89-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.09% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 218.1 | +18.89% | 4,330,840 |
24-04-25 | 183.4 | -0.20% | 1,124,546 |
24-04-24 | 183.8 | -0.24% | 973,428 |
24-04-23 | 184.2 | +2.15% | 1,202,959 |
24-04-22 | 180.4 | +0.84% | 1,218,743 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.76% | 32.03B | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- RMD Stock